SMCO3: A Unique Protein with Multiple Coiled-Coil Domains and Potential as A Drug Target Or Biomarker

Target Name: SMCO3

NCBI ID: G440087

SMCO3

Other Name(s): single-pass membrane protein with coiled-coil domains 3 | Single-pass membrane protein with coiled-coil domains 3 | Single-pass membrane and coiled-coil domain-containing protein 3 | SMCO3_HUMAN | C12orf69

SMCO3: A Unique Protein with Multiple Coiled-Coil Domains and Potential as A Drug Target Or Biomarker

Single-pass membrane protein with coiled-coil domains 3 (SMCO3) is a protein that is expressed in various cell types of the human body. It plays a crucial role in the regulation of various cellular processes that are essential for the survival of the cell. SMCO3 is a unique protein that has a single-pass membrane structure and contains multiple coiled-coil domains. These features make it an interesting candidate for drug targeting or biomarker research.

SMCO3 is a transmembrane protein that is involved in various cellular processes, including intracellular signaling, protein-protein interactions, and intracellular signaling pathways. It is a key regulator of the T-cell receptor (TCR) signaling pathway, which is essential for the development and activation of T-cells. SMCO3 plays a critical role in the regulation of TCR-induced signaling by interacting with the tyrosine kinase PDGFR-尾.

SMCO3 is also involved in the regulation of cell adhesion and migration. It is a key regulator of the cadherin-based signaling pathway, which is essential for the regulation of cell-cell adhesion and migration. SMCO3 plays a critical role in the regulation of cadherin-based signaling by interacting with the cadherin protein.

SMCO3 is also involved in the regulation of cell survival and apoptosis. It is a key regulator of the p53-based signaling pathway, which is essential for the regulation of cell survival and apoptosis. SMCO3 plays a critical role in the regulation of p53-based signaling pathway by interacting with the p53 protein.

SMCO3 is a unique protein that has a single-pass membrane structure and contains multiple coiled-coil domains. These features make it an interesting candidate for drug targeting or biomarker research. For example, SMCO3 can be used as a drug target for the treatment of various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases.

SMCO3 has also been identified as a potential biomarker for various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. For example, SMCO3 has been used as a biomarker for the diagnosis of various types of cancer, including breast cancer, lung cancer, and colon cancer. SMCO3 has also been used as a biomarker for the diagnosis of autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis.

In conclusion, SMCO3 is a unique protein that has a single-pass membrane structure and contains multiple coiled-coil domains. These features make it an interesting candidate for drug targeting or biomarker research. SMCO3 plays a crucial role in the regulation of various cellular processes that are essential for the survival of the cell. Therefore, SMCO3 is a potential drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand the role of SMCO3 in cellular signaling pathways and its potential as a drug target or biomarker.

Protein Name: Single-pass Membrane Protein With Coiled-coil Domains 3

The "SMCO3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMCO3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets